Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs

被引:101
作者
de la Sierra, Alejandro [1 ]
Banegas, Jose R. [2 ]
Oliveras, Anna [3 ]
Gorostidi, Manuel [4 ]
Segura, Julian [5 ]
de la Cruz, Juan J. [2 ]
Armario, Pedro [6 ]
Ruilope, Luis M. [5 ]
机构
[1] Univ Barcelona, Hosp Mutua Terrassa, Dept Internal Med, Terrassa 08221, Spain
[2] Autonomous Univ Madrid, Dept Prevent Med & Publ Hlth, E-28049 Madrid, Spain
[3] Hosp del Mar, Hypertens Unit, Barcelona, Spain
[4] Hosp Univ Cent Asturias, Dept Nephrol, Oviedo, Spain
[5] Hosp 12 Octubre, Hypertens Unit, E-28041 Madrid, Spain
[6] Hosp Gen LHosp, Dept Internal Med, Barcelona, Spain
关键词
ambulatory blood pressure monitoring; masked hypertension; resistant hypertension; target organ damage; white-coat hypertension; BLOOD-PRESSURE CONTROL; UNITED-STATES; PREVALENCE;
D O I
10.1097/HJH.0b013e328353634e
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background and aim: Clinical characteristics of resistant hypertensive patients in comparison to controlled patients have not been fully investigated in large cohorts. The aim of the study was to evaluate clinical differences, target organ damage and ambulatory blood pressure monitoring in resistant hypertensive patients and patients controlled on three or less drugs. Methods: In December 2010, from the Spanish Ambulatory Blood Pressure Monitoring Registry, we identified 14 461 patients fulfilling criteria of resistant hypertension and 13 436 hypertensive patients controlled on three or less drugs. Clinical characteristics were compared between these two groups. Results: Compared to controlled patients, those having resistant hypertension were older, more obese and had longer hypertension duration. They also had more frequently diabetes, dyslipidemia, reduced renal function, microalbuminuria, left-ventricular hypertrophy and previous history of cardiovascular events. In multivariate analyses, hypertension duration, obesity, abdominal obesity, left-ventricular hypertrophy, reduced estimated glomerular filtration rate, and microalbuminuria were independently associated with resistant hypertension. Resistant hypertensive patients had higher ambulatory blood pressures, but differences between office and ambulatory blood pressure (white-coat effect) were also more pronounced in this group, revealing a proportion of 40% of patients with normal 24-h blood pressure. On the contrary, values of 24-h blood pressure above 130 and/or 80mmHg (masked hypertension) were present in 31% of apparently controlled patients. Conclusion: Resistant hypertension is associated with obesity, longer hypertension duration and kidney and cardiac damage. Ambulatory blood pressure monitoring reveals that white-coat hypertension is common among resistant hypertensive patients, as well as is masked hypertension among apparently controlled patients.
引用
收藏
页码:1211 / 1216
页数:6
相关论文
共 16 条
[1]   Effectiveness of blood pressure control outside the medical setting [J].
Banegas, Jose R. ;
Segura, Julian ;
Sobrino, Javier ;
Rodriguez-Artalejo, Fernando ;
de la Sierra, Alejandro ;
de la Cruz, Juan J. ;
Gorostidi, Manuel ;
Sarria, Antonio ;
Ruilope, Luis M. .
HYPERTENSION, 2007, 49 (01) :62-68
[2]   Masked hypertension:: a systematic review [J].
Bobrie, Guillaume ;
Clerson, Pierre ;
Menard, Joel ;
Postel-Vinay, Nicolas ;
Chatellier, Gilles ;
Plouin, Pierre-Francois .
JOURNAL OF HYPERTENSION, 2008, 26 (09) :1715-1725
[3]   Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J].
Calhoun, David A. ;
Jones, Daniel ;
Textor, Stephen ;
Goff, David C. ;
Murphy, Timothy P. ;
Toto, Robert D. ;
White, Anthony ;
Cushman, William C. ;
White, William ;
Sica, Domenic ;
Ferdinand, Keith ;
Giles, Thomas D. ;
Falkner, Bonita ;
Carey, Robert M. .
HYPERTENSION, 2008, 51 (06) :1403-1419
[4]   Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension [J].
Clement, DL ;
De Buyzere, ML ;
De Bacquer, DA ;
de Leeuw, PW ;
Duprez, DA ;
Fagard, RH ;
Gheeraert, PJ ;
Missault, LH ;
Braun, JJ ;
Six, RO ;
Van Der Niepen, P ;
O'Brien, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (24) :2407-2415
[5]   High prevalence of cardiac and extracardiac target organ damage in refractory hypertension [J].
Cuspidi, C ;
Macca, G ;
Sampieri, L ;
Michev, I ;
Salerno, M ;
Fusi, V ;
Severgnini, B ;
Meani, S ;
Magrini, F ;
Zanchetti, A .
JOURNAL OF HYPERTENSION, 2001, 19 (11) :2063-2070
[6]   Evaluation and management of hypertension in Spain.: A consensus guide [J].
de la Sierra, Alejandro ;
Gorostidi, Manuel ;
Marin, Rafael ;
Redon, Josep ;
Banegas, Jose R. ;
Armario, Pedro ;
Puig, Juan Garcia ;
Zarco, Julio ;
Llisterri, Jose L. ;
Sanchis, Carlos ;
Abarca, Benjamin ;
Palomo, Vicente ;
Gomis, Ramon ;
Otero, Alfonso ;
Villar, Fernando ;
Honorato, Jesus ;
Tamargo, Juan ;
Lobos, Jose M. ;
Macias-Nunez, Juan ;
Sarria, Antonio ;
Aranda, Pedro ;
Ruilope, Luis M. .
MEDICINA CLINICA, 2008, 131 (03) :104-116
[7]   Clinical Features of 8295 Patients With Resistant Hypertension Classified on the Basis of Ambulatory Blood Pressure Monitoring [J].
de la Sierra, Alejandro ;
Segura, Julian ;
Banegas, Jose R. ;
Gorostidi, Manuel ;
de la Cruz, Juan J. ;
Armario, Pedro ;
Oliveras, Anna ;
Ruilope, Luis M. .
HYPERTENSION, 2011, 57 (05) :898-U74
[8]   Prevalence and Factors Associated With Circadian Blood Pressure Patterns in Hypertensive Patients [J].
de la Sierra, Alejandro ;
Redon, Josep ;
Banegas, Jose R. ;
Segura, Julian ;
Parati, Gianfranco ;
Gorostidi, Manuel ;
de la Cruz, Juan J. ;
Sobrino, Javier ;
Llisterri, Jose L. ;
Alonso, Javier ;
Vinyoles, Ernest ;
Pallares, Vicente ;
Sarria, Antonio ;
Aranda, Pedro ;
Ruilope, Luis M. .
HYPERTENSION, 2009, 53 (03) :466-U15
[9]   Uncontrolled and Apparent Treatment Resistant Hypertension in the United States, 1988 to 2008 [J].
Egan, Brent M. ;
Zhao, Yumin ;
Axon, R. Neal ;
Brzezinski, Walter A. ;
Ferdinand, Keith C. .
CIRCULATION, 2011, 124 (09) :1046-1058
[10]   Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk [J].
Gupta, Ajay K. ;
Nasothimiou, Efthimia G. ;
Chang, Choon L. ;
Sever, Peter S. ;
Dahlof, Bjorn ;
Poulter, Neil R. .
JOURNAL OF HYPERTENSION, 2011, 29 (10) :2004-2013